Results 261 to 270 of about 645,542 (342)
ESR Essentials: renal imaging in children-practice recommendations by the European Society of Paediatric Radiology. [PDF]
Woźniak MM +12 more
europepmc +1 more source
Abstract A 4‐month‐old, intact female, Golden Retriever presented with lifelong urinary incontinence. Initial diagnostics revealed mild leukocytosis, regenerative anaemia, mild azotemia and bacteriuria with Escherichia coli. Abdominal computed tomography identified bilateral intramural ectopic ureters (EUs) with severe hydroureters, bilateral renal ...
Miruna Munteanu +3 more
wiley +1 more source
Renaming Medullary Cystic Kidney Disease: A Review of Semantic Nomenclature. [PDF]
Kuang K +5 more
europepmc +1 more source
This study demonstrates the significant clinical utility of Mixed Reality (MR) in Thoracic Endovascular Aortic Repair (TEVAR). Our findings reveal that MR‐assisted workflows enhance patient comprehension and satisfaction preoperatively and provide intuitive intraoperative navigation.
Jian‐Jun Gu +3 more
wiley +1 more source
Lack of ANKMY2 suppresses kidney cystogenesis in embryonic- and adult-onset polycystic kidney disease. [PDF]
Hwang SH +7 more
europepmc +1 more source
Intestinal Atresia in Finland: Maternal Risk Factors, Prevalence, Associated Anomalies and Survival
ABSTRACT Aim We aimed to investigate prevalence, associated anomalies and survival of congenital intestinal atresia and to examine maternal risk factors for jejunoileal atresia (JIA). Methods All children born with, or pregnancies terminated because of, JIA or colonic atresia (CA) in Finland during 1987–2019 were identified from the Finnish Register of
Esko Tahkola +9 more
wiley +1 more source
Generation of Mice Harboring Bicc1 Conditional Null Alleles. [PDF]
Liu CF +4 more
europepmc +1 more source
Novel drugs approved by the EMA, the FDA and the MHRA in 2025: A year in review
Abstract In the 2025 novel drug mini‐review, one can take a full measure of the ingenuity that underlies current drug design and development, despite the year's smaller harvest (46 novel drugs) compared to 2024 (53) and 2023 (70). 54% of the novel drugs are first‐in‐class (FIC).
Andreas Papapetropoulos +16 more
wiley +1 more source
Emerging roles of ATP citrate lyase in kidney diseases: from pathogenic driver to therapeutic target. [PDF]
Wei M +7 more
europepmc +1 more source

